Literature DB >> 1721271

Four-hour versus 24-hour intravenous infusion of FK 506 in liver transplantation.

K M Abu-Elmagd1, J Fung, R Draviam, W Shannon, A Jain, M Alessiani, S Takaya, R Venkataramanan, V S Warty, A Tzakis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721271      PMCID： PMC2955417     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

1.  Pharmacokinetics of FK 506: preclinical and clinical studies.

Authors:  R Venkataramanan; A Jain; E Cadoff; V Warty; K Iwasaki; K Nagase; A Krajack; O Imventarza; S Todo; J J Fung
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

2.  Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations.

Authors:  A B Jain; R Venkataramanan; E Cadoff; J J Fung; S Todo; A Krajack; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

3.  Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine.

Authors:  R Venkataramanan; A Jain; V W Warty; K Abu-Elmagd; H Furakawa; O Imventarza; J Fung; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

Review 4.  Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics.

Authors:  T E Starzl; K Abu-Elmagd; A Tzakis; J J Fung; K A Porter; S Todo
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

5.  The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver.

Authors:  K Abu-Elmagd; J J Fung; M Alessiani; A Jain; R Venkataramanan; V S Warty; S Takaya; S Todo; W D Shannon; T E Starzl
Journal:  Transplantation       Date:  1991-07       Impact factor: 4.939

6.  A highly sensitive method to assay FK-506 levels in plasma.

Authors:  K Tamura; M Kobayashi; K Hashimoto; K Kojima; K Nagase; K Iwasaki; T Kaizu; H Tanaka; M Niwa
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066
  6 in total
  6 in total

Review 1.  Immunosuppression and allograft rejection following lung transplantation: evidence to date.

Authors:  Gregory I Snell; Glen P Westall; Miranda A Paraskeva
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

2.  Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience.

Authors:  K Abu-Elmagd; S Todo; J Fung; J Demetris; J Rakela; A S Rao; S Iwatsuki; T Starzl
Journal:  Clin Transpl       Date:  1994

3.  Adverse effects of FK 506 overdosage after liver transplantation.

Authors:  M Alessiani; U Cillo; J J Fung; W Irish; K Abu-Elmagd; A Jain; S Takaya; D Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

Review 4.  Immunosuppression in Lung Transplantation.

Authors:  Joelle Nelson; Elisabeth Kincaide; Jamie Schulte; Reed Hall; Deborah Jo Levine
Journal:  Handb Exp Pharmacol       Date:  2022

Review 5.  The current status of hepatic transplantation at the University of Pittsburgh.

Authors:  K Abu-Elmagd; J Fung; S Todo; A Rao; J Reyes; J Demetris; G Mazariegos; P Fontes; J McMichael; H Furukawa
Journal:  Clin Transpl       Date:  1995

6.  Recent advances in hepatic transplantation at the University of Pittsburgh.

Authors:  K Abu-Elmagd; O Bronsther; A Jain; W Irish; H Ramos; I R Marino; F Dodson; R Selby; H Doyle; H Furukawa
Journal:  Clin Transpl       Date:  1993
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.